Cargando…

Effectiveness and safety of benralizumab for severe asthma in clinical practice (J-BEST): a prospective study

BACKGROUND: Benralizumab is a humanized, fucosylated, monoclonal antibody that targets the interleukin 5 (IL-5) α receptor. Several phase III trials have shown that benralizumab can significantly reduce the incidence of acute exacerbations and improve lung function in patients with severe asthma. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Izumo, Takehiro, Tone, Mari, Kuse, Naoyuki, Awano, Nobuyasu, Tanaka, Atsuko, Jo, Tatsunori, Yoshimura, Hanako, Minami, Jonsu, Takada, Kohei, Inomata, Minoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210162/ https://www.ncbi.nlm.nih.gov/pubmed/32395482 http://dx.doi.org/10.21037/atm.2020.04.01

Ejemplares similares

Rapid and sustained effects of a single dose of benralizumab on chronic eosinophilic pneumonia
por: Izumo, Takehiro, et al.
Publicado: (2020)

Rapid effects of benralizumab on severe asthma during surgery for residual tumor after advanced lung squamous cell carcinoma treatment with pembrolizumab
por: Izumo, Takehiro, et al.
Publicado: (2019)

High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non‐small cell lung cancer
por: Tone, Mari, et al.
Publicado: (2019)

Usefulness of Measurement of End-tidal CO(2) Using a Portable Capnometer in Patients with Chronic Respiratory Failure Receiving Long-term Oxygen Therapy
por: Jo, Tatsunori, et al.
Publicado: (2020)

Comparison of adequacy between transbronchial lung cryobiopsy samples and endobronchial ultrasound‐guided transbronchial needle aspiration samples for next‐generation sequencing analysis
por: Tone, Mari, et al.
Publicado: (2020)

Efficacy and safety of semi-flexible thoracoscopic cryobiopsy in the diagnosis of elderly tuberculous pleurisy
por: Jo, Tatsunori, et al.
Publicado: (2020)

Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma
por: Akagi, Yu, et al.
Publicado: (2020)

The 2014 autochthonous dengue fever outbreak in Tokyo: A case series study and assessment of the causes and preventive measures
por: Kori, Mayuko, et al.
Publicado: (2020)

Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis Complicated by Unilateral Right-sided Interstitial Lung Disease
por: Kori, Mayuko, et al.
Publicado: (2020)

Prospective multicentre study on the safety and utility of transbronchial lung cryobiopsy with endobronchial balloon
por: Inomata, Minoru, et al.
Publicado: (2020)

Treatment effect and safety profile of salvage chemotherapy following immune checkpoint inhibitors in lung cancer
por: Tone, Mari, et al.
Publicado: (2019)

The combination of EBUS-TBNA and the PAB antibody led to a successful treatment for lung cancer in a patient with asymptomatic sarcoidosis mimicking nodal metastasis
por: Tone, Mari, et al.
Publicado: (2018)

Utility of radial endobronchial ultrasonography combined with transbronchial lung cryobiopsy in patients with diffuse parenchymal lung diseases: a multicentre prospective study
por: Inomata, Minoru, et al.
Publicado: (2021)

A case of pulmonary sclerosing pneumocytoma diagnosed preoperatively using transbronchial cryobiopsy
por: Muto, Yutaka, et al.
Publicado: (2021)

Predictive model for the development of critical coronavirus disease 2019 and its risk factors among patients in Japan
por: Muto, Yutaka, et al.
Publicado: (2021)

Drug-induced hypersensitivity syndrome caused by minodronic acid hydrate
por: Muto, Yutaka, et al.
Publicado: (2021)

An autopsy case of idiopathic pulmonary fibrosis with remarkable honeycomb cyst expansion
por: Ito, Yu, et al.
Publicado: (2022)

Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019
por: Awano, Nobuyasu, et al.
Publicado: (2020)

Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in Japan
por: Izumo, Takehiro, et al.
Publicado: (2021)

Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19
por: Izumo, Takehiro, et al.
Publicado: (2021)

Body mass index and in-hospital mortality in patients with acute exacerbation of idiopathic pulmonary fibrosis
por: Awano, Nobuyasu, et al.
Publicado: (2021)

Anxiety, Depression, and Resilience of Healthcare Workers in Japan During the Coronavirus Disease 2019 Outbreak
por: Awano, Nobuyasu, et al.
Publicado: (2020)

Spontaneous Muscle Hematoma in Japanese Patients with Severe COVID-19 Treated with Unfractionated Heparin: Two Case Reports
por: Ito, Yu, et al.
Publicado: (2021)

Pulmonary amyloidosis diagnosed via transbronchial lung cryobiopsy without surgical lung biopsy: A case series
por: Fujimoto, Kazushi, et al.
Publicado: (2022)

Adult T-cell leukemia/lymphoma complicated by Pneumocystis pneumonia in a non-endemic area
por: Kunimoto, Mayu, et al.
Publicado: (2023)

Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: a nationwide observational study
por: Awano, Nobuyasu, et al.
Publicado: (2022)

Polymyxin B-immobilised fibre column treatment for acute exacerbation of idiopathic pulmonary fibrosis patients with mechanical ventilation: a nationwide observational study
por: Awano, Nobuyasu, et al.
Publicado: (2023)

Uniportal thoracoscopic extended right apical segmentectomy with virtual-assisted lung mapping: a case report
por: Yanagiya, Masahiro, et al.
Publicado: (2023)

Effectiveness of benralizumab for allergic and eosinophilic predominant asthma following negative initial results with omalizumab
por: Minami, Daisuke, et al.
Publicado: (2018)

The Significant Antitumor Activity of Nivolumab in Lung Adenocarcinoma with Choriocarcinomatous Features
por: Ochi, Mieko, et al.
Publicado: (2018)

The clinical profile of benralizumab in the management of severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
por: Just, Jocelyne, et al.
Publicado: (2020)

Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma
por: Noorduyn, Stephen G., et al.
Publicado: (2021)

Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma
por: Gómez-Bastero Fernández, Ana, et al.
Publicado: (2022)

A case of vildagliptin-induced interstitial pneumonia
por: Kuse, Naoyuki, et al.
Publicado: (2016)

Benralizumab: a unique IL-5 inhibitor for severe asthma
por: Tan, Laren D, et al.
Publicado: (2016)

Population Pharmacokinetic Modeling of Benralizumab in Adult and Adolescent Patients with Asthma
por: Yan, Li, et al.
Publicado: (2019)

Population Pharmacokinetics and Pharmacodynamics of Benralizumab in Healthy Volunteers and Patients With Asthma
por: Wang, B, et al.
Publicado: (2017)

Postbronchodilator lung function improvements with benralizumab for patients with severe asthma
por: Mathur, Sameer K., et al.
Publicado: (2020)

Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma
por: Moran, Angela M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5np21ta5h8385p472uliveisik